| Trial arm 1 Median comparator & benefit framing (n = 2576) | Trial arm 2 Top quartile comparator & benefit framing (n = 2958) | Trial arm 3 Median comparator & risk framing (n = 3089) | Trial arm 4 Top quartile comparator & risk framing (n = 2394) | Total (n = 11,017) |
---|---|---|---|---|---|
Sex, n (%) | |||||
 Female | 1847 (71.7%) | 2169 (73.3%) | 2285 (74.0%) | 1696 (70.8%) | 7,997 (72.6%) |
 Male | 729 (28.3%) | 789 (26.7%) | 804 (26.0%) | 698 (29.2%) | 3,020 (27.4%) |
Age | |||||
 Mean ± SD | 86.36 ± 7.87 | 86.32 ± 7.92 | 86.40 ± 7.66 | 86.32 ± 7.78 | 86.35 ± 7.80 |
Charlson Comorbidity Index | |||||
 Mean ± SD | 1.71 ± 1.56 | 1.73 ± 1.62 | 1.70 ± 1.58 | 1.76 ± 1.59 | 1.72 ± 1.59 |
Diagnosis, n (%) | |||||
 Psychosis | 132 (5.1%) | 166 (5.6%) | 148 (4.8%) | 112 (4.7%) | 558 (5.1%) |
 Dementia | 2127 (82.6%) | 2326 (78.6%) | 2594 (84.0%) | 2011 (84.0%) | 9,058 (82.2%) |
 Neither | 317 (12.3%) | 466 (15.8%) | 347 (11.2%) | 271 (11.3%) | 1,401 (12.7%) |
Level of function | |||||
 Mean ± SD | 17.18 ± 7.05 | 16.26 ± 7.42 | 16.93 ± 7.20 | 16.93 ± 7.51 | 16.81 ± 7.30 |
Pain score | |||||
 Mean ± SD | 0.37 ± 0.64 | 0.39 ± 0.65 | 0.39 ± 0.66 | 0.42 ± 0.69 | 0.39 ± 0.66 |
Depression score | Â | ||||
 Mean ± SD | 2.08 ± 2.36 | 2.43 ± 2.45 | 1.94 ± 2.32 | 1.90 ± 2.44 | 2.10 ± 2.40 |
 Recent fall(s), n (%) | 476 (18.5%) | 518 (17.5%) | 600 (19.4%) | 420 (17.5%) | 2,014 (18.3%) |
 Recent psychiatric consult, n (%) | 230 (8.9%) | 382 (12.9%) | 393 (12.7%) | 252 (10.5%) | 1,257 (11.4%) |
 Recent geriatric consult, n (%) | 125 (4.9%) | 111 (3.8%) | 174 (5.6%) | 160 (6.7%) | 570 (5.2%) |
 Recent restraint use, n (%) | 90 (3.5%) | 209 (7.1%) | 142 (4.6%) | 107 (4.5%) | 548 (5.0%) |
Aggressive behaviour | |||||
 Mean ± SD | 1.44 ± 2.17 | 1.56 ± 2.22 | 1.50 ± 2.19 | 1.45 ± 2.26 | 1.49 ± 2.21 |
Prescriptions, n (%) | |||||
 Antipsychotics | 668 (25.9%) | 839 (28.4%) | 797 (25.8%) | 619 (25.9%) | 2,923 (26.5%) |
 Opioids | 655 (25.4%) | 829 (28.0%) | 758 (24.5%) | 622 (26.0%) | 2,864 (26.0%) |
 Benzodiazepines | 355 (13.8%) | 457 (15.4%) | 389 (12.6%) | 326 (13.6%) | 1,527 (13.9%) |
 Antidepressants | 1335 (51.8%) | 1678 (56.7%) | 1496 (48.4%) | 1191 (49.7%) | 5,700 (51.7%) |